Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis

Journal of Experimental Medicine

Volumn 204, Issue 5, 2007, Pages 1057-1069

  Arnold, Ludovic ^a   Henry, Adeline ^a   Poron, Françoise ^a   Baba Amer, Yasmine ^a   Van Rooijen, Nico ^b   Plonquet, Anne ^c   Gherardi, Romain K ^a   Chazaud, Bénédicte ^a  

^a UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

^c HENRI MONDOR HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MYOGENIN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; IN VITRO STUDY; IN VIVO STUDY; MACROPHAGE; MONOCYTE; MOUSE; MUSCLE DEVELOPMENT; MUSCLE FUNCTION; MUSCLE INJURY; MUSCLE REGENERATION; MYOTUBE; NONHUMAN; PHAGOCYTOSIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANTIGENS, CD11B; CELL DIFFERENTIATION; DNA PRIMERS; GREEN FLUORESCENT PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MACROPHAGES; MICE; MICE, MUTANT STRAINS; MICROSPHERES; MONOCYTES; MUSCLE DEVELOPMENT; MUSCLE, SKELETAL; PHAGOCYTOSIS; RECEPTORS, CHEMOKINE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 34248997759     PISSN: 00221007     EISSN: 00221007     Source Type: Journal    
DOI: 10.1084/jem.20070075     Document Type: Article

References (79)

1. Lapidot, T., and I. Petit. 2002. Current understanding of stem cell mobilization: the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells. Exp. Hematol. 30:973-981.
2. Gordon, S., and P.R. Taylor. 2005. Monocyte and macrophage heterogeneity. Nat. Rev. Immunol. 5:953-964.
3. Gordon, S. 1995. The macrophage. Bioessays. 17:977-986.
4. Stout, R.D., and J. Suttles. 2004. Functional plasticity of macrophages: reversible adaptation to changing microenvironments. J. Leukoc. Biol. 76:509-513.
5. Gordon, S. 2003. Alternative activation of macrophages. Nat. Rev. Immunol. 3:23-35.
6. Gratchev, A., J. Kzhyshkowska, K. Kothe, I. Muller-Molinet, S. Kannookadan, J. Utikal, and S. Goerdt. 2006. Mphi1 and Mphi2 can be re-polarized by Th2 or Th1 cytokines, respectively, and respond to exogenous danger signals. Immunobiology. 211:473-486.
7. Porcheray, F., S. Viaud, A.C. Rimaniol, C. Leone, B. Samah, N. Dereuddre-Bosquet, D. Dormont, and G. Gras. 2005. Macrophage activation switching: an asset for the resolution of inflammation. Clin. Exp. Immunol. 142:481-489.
8. Stout, R.D., C. Jiang, B. Matta, I. Tietzel, S.K. Watkins, and J. Suttles. 2005. Macrophages sequentially change their functional phenotype in response to changes in microenvironmental influences. J. Immunol. 175:342-349.
9. Geissmann, F., S. Jung, and D.R. Littman. 2003. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity. 19:71-82.
10. Ancuta, P., L. Weiss, and N. Haeffner-Cavaillon. 2000. CD14+CD16++ cells derived in vitro from peripheral blood monocytes exhibit phenotypic and functional dendritic cell-like characteristics. Eur. J. Immunol. 30:1872-1883.
11. Sunderkotter, C., T. Nikolic, M.J. Dillon, N. van Rooijen, M. Stehling, D.A. Drevets, and P.J. Leenen. 2004. Subpopulations of mouse blood monocytes differ in maturation stage and inflammatory response. J. Immunol. 172:4410-4417.
12. Tacke, F., D. Alvarez, T.J. Kaplan, C. Jakubzick, R. Spanbroek, J. Llodra, A. Garin, J. Liu, M. Mack, N. van Rooijen, et al. 2007. Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. J. Clin. Invest. 117:185-194.
13. Swirski, F.K., P. Libby, E. Aikawa, P. Alcaide, F.W. Luscinskas, R. Weissleder, and M.J. Pittet. 2007. Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata. J. Clin. Invest. 117:195-205.
14. Fingerle, G., A. Pforte, B. Passlick, M. Blumenstein, M. Strobel, and H.W. Ziegler-Heitbrock. 1993. The novel subset of CD14+/CD16+ blood monocytes is expanded in sepsis patients. Blood. 82:3170-3176.
15. Tacke, F., F. Ginhoux, C. Jakubzick, N. van Rooijen, M. Merad, and G.J. Randolph. 2006. Immature monocytes acquire antigens from other cells in the bone marrow and present them to T cells after maturing in the periphery. J. Exp. Med. 203:583-597.
16. Varol, C., L. Landsman, D.K. Fogg, L. Greenshtein, B. Gildor, R. Margalit, V. Kalchenko, F. Geissmann, and S. Jung. 2007. Monocytes give rise to mucosal, but not splenic, conventional dendritic cells. J. Exp. Med. 204:171-180.
17. McLennan, I.S. 1996. Degenerating and regenerating skeletal muscles contain several subpopulations of macrophages with distinct spatial and temporal distributions. J. Anat. 188:17-28.
18. Pimorady-Esfahani, A., M.D. Grounds, and P.G. McMenamin. 1997. Macrophages and dendritic cells in normal and regenerating murine skeletal muscle. Muscle Nerve. 20:158-166.
19. Contreras-Shannon, V., O. Ochoa, S.M. Reyes-Reyna, D. Sun, J.E. Michalek, W.A. Kuziel, L.M. McManus, and P.K. Shireman. 2007. Fat accumulation with altered inflammation and regeneration in skeletal muscle of CCR2 -/- mice following ischemic injury. Am. J. Physiol. Cell Physiol. 292:C953-C967.
20. Shireman, P.K., V. Contreras-Shannon, O. Ochoa, B.P. Karia, J.E. Michalek, and L.M. McManus. 2006. MCP-1 deficiency causes altered inflammation with impaired skeletal muscle regeneration. J. Leukoc. Biol. 81:775-785; 10.1189/jlb.0506356.
21. Summan, M., G.L. Warren, R.R. Mercer, R. Chapman, T. Hulderman, N. van Rooijen, and P.P. Simeonova. 2006. Macrophages and skeletal muscle regeneration: a clodronate-containing liposome depletion study. Am. J. Physiol. Regul. Integr. Comp. Physiol. 290:R1488-R1495.
22. Warren, G.L., T. Hulderman, D. Mishra, X. Gao, L. Millecchia, L. O'Farrell, W.A. Kuziel, and P.P. Simeonova. 2004. Chemokine receptor CCR2 involvement in skeletal muscle regeneration. FASEB J. 19:413-415.
23. Grounds, M.D. 1987. Phagocytosis of necrotic muscle in muscle isografts is influenced by the strain, age, and sex of host mice. J. Pathol. 153:71-82.
24. Robertson, T.A., M.A.L. Maley, M.D. Grounds, and J.M. Papadimitriou. 1993. The role of macrophages in skeletal muscle regeneration with particular reference to chemotaxis. Exp. Cell Res. 207:321-331.
25. Cantini, M., and U. Carraro. 1995. Macrophage-released factor stimulates selectively myogenic cells in primary muscle culture. J. Neuropathol. Exp. Neurol. 54:121-128.
26. Chazaud, B., C. Sonnet, P. Lafuste, G. Bassez, A.C. Rimaniol, F. Poron, F.J. Authier, P.A. Dreyfus, and R.K. Gherardi. 2003. Satellite cells attract monocytes and use macrophages as a support to escape apoptosis and enhance muscle growth. J. Cell Biol. 163:1133-1143.
27. Sonnet, C., P. Lafuste, L. Arnold, M. Brigitte, F. Poron, F.J. Authier, F. Chretien, R.K. Gherardi, and B. Chazaud. 2006. Human macrophages rescue myoblasts and myotubes from apoptosis through a set of adhesion molecular systems. J. Cell Sci. 119:2497-2507.
28. St Pierre, B.A., and J.G. Tidball. 1994. Differential response of macrophage subpopulations to soleus muscle reloading after rat hindlimb suspension. J. Appl. Physiol. 77:290-297.
29. Jin, F., C.F. Nathan, D. Radzioch, and A. Ding. 1998. Lipopolysaccharide-related stimuli induce expression of the secretory leukocyte protease inhibitor, a macrophage-derived lipopolysaccharide inhibitor. Infect. Immun. 66:2447-2452.
30. Jin, F.Y., C. Nathan, D. Radzioch, and A. Ding. 1997. Secretory leukocyte protease inhibitor: a macrophage product induced by and antagonistic to bacterial lipopolysaccharide. Cell. 88:417-426.
31. Nathan, C. 2002. Points of control in inflammation. Nature. 420:846-852.
32. Odaka, C., T. Mizuochi, J. Yang, and A. Ding. 2003. Murine macrophages produce secretory leukocyte protease inhibitor during clearance of apoptotic cells: implications for resolution of the inflammatory response. J. Immunol. 171:1507-1514.
33. Ricote, M., A.C. Li, T.M. Willson, C.J. Kelly, and C.K. Glass. 1998. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature. 391:79-82.
34. Moore, K.J., M.L. Fitzgerald, and M.W. Freeman. 2001. Peroxisome proliferator-activated receptors in macrophage biology: friend or foe? Curr. Opin. Lipidol. 12:519-527.
35. Alleva, D.G., E.B. Johnson, F.M. Lio, S.A. Boehme, P.J. Conlon, and P.D. Crowe. 2002. Regulation of murine macrophage proinflammatory and anti-inflammatory cytokines by ligands for peroxisome proliferator-activated receptor-gamma: counter-regulatory activity by IFN-gamma. J. Leukoc. Biol. 71:677-685.
36. Hogger, P., J. Dreier, A. Droste, F. Buck, and C. Sorg. 1998. Identification of the integral membrane protein RM3/1 on human monocytes as a glucocorticoid-inducible member of the scavenger receptor cysteine-rich family (CD163). J. Immunol. 161:1883-1890.
37. Stein, M., S. Keshav, N. Harris, and S. Gordon. 1992. Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J. Exp. Med. 176:287-292.
38. Horsley, V., K.M. Jansen, S.T. Mills, and G.K. Pavlath. 2003. IL-4 acts as a myoblast recruitment factor during mammalian muscle growth. Cell. 113:483-494.
39. Song, E., N. Ouyang, M. Horbelt, B. Antus, M. Wang, and M.S. Exton. 2000. Influence of alternatively and classically activated macrophages on fibrogenic activities of human fibroblasts. Cell. Immunol. 204:19-28.
40. Lucas, M., L.M. Stuart, A. Zhang, K. Hodivala-Dilke, M. Febbraio, R. Silverstein, J. Savill, and A. Lacy-Hulbert. 2006. Requirements for apoptotic cell contact in regulation of macrophage responses. J. Immunol. 177:4047-4054.
41. Cvetanovic, M., and D.S. Ucker. 2004. Innate immune discrimination of apoptotic cells: repression of proinflammatory macrophage transcription is coupled directly to specific recognition. J. Immunol. 172:880-889.
42. Brouckaert, G., M. Kalai, D.V. Krysko, X. Saelens, D. Vercammen, M. Ndlovu, G. Haegeman, K. D'Herde, and P. Vandenabeele. 2004. Phagocytosis of necrotic cells by macrophages is phosphatidylserine dependent and does not induce inflammatory cytokine production. Mol. Biol. Cell. 15:1089-1100.
43. Fadok, V.A., D.L. Bratton, L. Guthrie, and P.M. Henson. 2001. Differential effects of apoptotic versus lysed cells on macrophage production of cytokines: role of proteases. J. Immunol. 166:6847-6854.
44. Huynh, M.L., V.A. Fadok, and P.M. Henson. 2002. Phosphatidylserine- dependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation. J. Clin. Invest. 109:41-50.
45. Savill, J., and V. Fadok. 2000. Corpse clearance defines the meaning of cell death. Nature. 407:784-788.
46. Xu, W., A. Roos, N. Schlagwein, A.M. Woltman, M.R. Daha, and C. van Kooten. 2006. IL-10-producing macrophages preferentially clear early apoptotic cells. Blood. 107:4930-4937.
47. Duffield, J.S., S.J. Forbes, C.M. Constandinou, S. Clay, M. Partolina, S. Vuthoori, S. Wu, R. Lang, and J.P. Iredale. 2005. Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J. Clin. Invest. 115:56-65.
48. Ginhoux, F., F. Tacke, V. Angeli, M. Bogunovic, M. Loubeau, X.M. Dai, E.R. Stanley, G.J. Randolph, and M. Merad. 2006. Langerhans cells arise from monocytes in vivo. Nat. Immunol. 7:265-273.
49. De Rossi, M., P. Bernasconi, F. Baggi, R. de Waal Malefyt, and R. Mantegazza. 2000. Cytokines and chemokines are both expressed by human myoblasts: possible relevance for the immune pathogenesis of muscle inflammation. Int. Immunol. 12:1329-1335.
50. Hirata, A., S. Masuda, T. Tamura, K. Kai, K. Ojima, A. Fukase, K. Motoyoshi, K. Kamakura, Y. Miyagoe-Suzuki, and S. Takeda. 2003. Expression profiling of cytokines and related genes in regenerating skeletal muscle after cardiotoxin injection: a role for osteopontin. Am. J. Pathol. 163:203-215.
51. Zhao, P., S. Iezzi, E. Carver, D. Dressman, T. Gridley, V. Sartorelli, and E.P. Hoffman. 2002. Slug is a novel downstream target of MyoD. Temporal profiling in muscle regeneration. J. Biol. Chem. 277:30091-30101.
52. Lumeng, C.N., J.L. Bodzin, and A.R. Saltiel. 2007. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J. Clin. Invest. 117:175-184.
53. Fujiwara, N., and K. Kobayashi. 2005. Macrophages in inflammation. Curr. Drug Targets Inflamm. Allergy. 4:281-286.
54. Serhan, C.N., and J. Savill. 2005. Resolution of inflammation: the beginning programs the end. Nat. Immunol. 6:1191-1197.
55. Hirt, U.A., and M. Leist. 2003. Rapid, noninflammatory and PS-dependent phagocytic clearance of necrotic cells. Cell Death Differ. 10:1156-1164.
56. Celada, A., and R.A. Maki. 1992. Transforming growth factor-beta enhances the M-CSF and GM-CSF-stimulated proliferation of macrophages. J. Immunol. 148:1102-1105.
57. Valledor, A.F., M. Comalada, J. Xaus, and A. Celada. 2000. The differential time-course of extracellular-regulated kinase activity correlates with the macrophage response toward proliferation or activation. J. Biol. Chem. 275:7403-7409.
58. Xaus, J., M. Cardo, A.F. Valledor, C. Soler, J. Lloberas, and A. Celada. 1999. Interferon gamma induces the expression of p21waf-1 and arrests macrophage cell cycle, preventing induction of apoptosis. Immunity. 11:103-113.
59. Gordon, S. 1999. Macrophage-restricted molecules: role in differentiation and activation. Immunol. Lett. 65:5-8.
60. Gonzalez-Juarrero, M., and I.M. Orme. 2001. Characterization of murine lung dendritic cells infected with Mycobacterium tuberculosis. Infect. Immun. 69:1127-1133.
61. Liu, G., X.P. Xia, S.L. Gong, and Y. Zhao. 2006. The macrophage heterogeneity: difference between mouse peritoneal exudate and splenic F4/80+ macrophages. J. Cell. Physiol. 209:341-352.
62. Carenini, S., M. Maurer, A. Werner, H. Blazyca, K.V. Toyka, C.D. Schmid, G. Raivich, and R. Martini. 2001. The role of macrophages in demyelinating peripheral nervous system of mice heterozygously deficient in p0. J. Cell Biol. 152:301-308.
63. Wehling, M., M.J. Spencer, and J.G. Tidball. 2001. A nitric oxide synthase transgene ameliorates muscular dystrophy in mdx mice. J. Cell Biol. 155:123-131.
64. Luk, H.W., L.J. Noble, and Z. Werb. 2003. Macrophages contribute to the maintenance of stable regenerating neurites following peripheral nerve injury. J. Neurosci. Res. 73:644-658.
65. Pull, S.L., J.M. Doherty, J.C. Mills, J.I. Gordon, and T.S. Stappenbeck. 2004. Activated macrophages are an adaptive element of the colonic epithelial progenitor niche necessary for regenerative responses to injury. Proc. Natl. Acad. Sci. USA. 102:99-104.
66. Rai, R.M., S. Loffreda, C.L. Karp, S.Q. Yang, H.Z. Lin, and A.M. Diehl. 1997. Kupffer cell depletion abolishes induction of interleukin-10 and permits sustained overexpression of tumor necrosis factor alpha messenger RNA in the regenerating rat liver. Hepatology. 25:889-895.
67. Rapalino, O., O. Lazarov-Spiegler, E. Agranov, G.J. Velan, E. Yoles, M. Fraidakis, A. Solomon, R. Gepstein, A. Katz, M. Belkin, et al. 1998. Implantation of stimulated homologous macrophages results in partial recovery of paraplegic rats. Nat. Med. 4:814-821.
68. Sadahira, Y., and M. Mori. 1999. Role of the macrophage in erythropoiesis. Pathol. Int. 49:841-848.
69. Diemel, L.T., S.J. Jackson, and M.L. Cuzner. 2003. Role for TGF-beta1, FGF-2 and PDGF-AA in a myelination of CNS aggregate cultures enriched with macrophages. J. Neurosci. Res. 74:858-867.
70. Butovsky, O., Y. Ziv, A. Schwartz, G. Landa, A.E. Talpalar, S. Pluchino, G. Martino, and M. Schwartz. 2006. Microglia activated by IL-4 or IFN-gamma differentially induce neurogenesis and oligodendrogenesis from adult stem/progenitor cells. Mol. Cell. Neurosci. 31:149-160.
71. Langen, R.C., J.L. Van Der Velden, A.M. Schols, M.C. Kelders, E.F. Wouters, and Y.M. Janssen-Heininger. 2004. Tumor necrosis factor-alpha inhibits myogenic differentiation through MyoD protein destabilization. FASEB J. 18:227-237.
72. Li, Y.P. 2003. TNF-alpha is a mitogen in skeletal muscle. Am. J. Physiol. Cell Physiol. 285:C370-C376.
73. Broussard, S.R., R.H. McCusker, J.E. Novakofski, K. Strle, W.H. Shen, R.W. Johnson, R. Dantzer, and K.W. Kelley. 2004. IL-1beta impairs insulin-like growth factor i-induced differentiation and down-stream activation signals of the insulin-like growth factor i receptor in myoblasts. J. Immunol. 172:7713-7720.
74. Lefaucheur, J.P., and A. Sebille. 1995. Muscle regeneration following injury can be modified in vivo by immune neutralization of basic fibroblast growth factor, transforming growth factor beta 1 or insulin-like growth factor I. J. Neuroimmunol. 57:85-91.
75. Bondesen, B.A., S.T. Mills, and G.K. Pavlath. 2006. The COX-2 pathway regulates growth of atrophied muscle via multiple mechanisms. Am. J. Physiol. Cell Physiol. 290:C1651-C1659.
76. Horsley, V., and G.K. Pavlath. 2003. Prostaglandin F2α stimulates growth of skeletal muscle cells via an NFATC2-dependent pathway. J. Cell Biol. 161:111-118.
77. Shen, W., V. Prisk, Y. Li, W. Foster, and J. Huard. 2006. Inhibited skeletal muscle healing in cyclooxygenase-2 gene-deficient mice: the role of PGE2 and PGF2alpha. J. Appl. Physiol. 101:1215-1221.
78. Tidball, J.G., and M. Wehling-Henricks. 2007. Macrophages promote muscle membrane repair and muscle fiber growth and regeneration during modified muscle loading in vivo. J. Physiol. 578:327-336.
79. van Rooijen, N., and A. Sanders. 1994. Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J. Immunol. Methods. 174:83-93.